Year: 2018

La Marató de TV3 funds four infectious disease research projects with IDIBELL researchers

La Marató de TV3 and Catalunya Radio of 2017, dedicated to infectious diseases, will fund a total of 36 scientific research projects of excellence, four of which including IDIBELL researchers. Two of these projects are led by doctors from Bellvitge University Hospital (HUB).   The first one, led by Dr. Jordi Carratalá, coordinator of IDIBELL’s …

La Marató de TV3 funds four infectious disease research projects with IDIBELL researchers Read More »

Open Access Week at IDIBELL

The theme for the 2018 International Open Access Week, to be held October 22-28, will be “designing equitable foundations for open knowledge.”   This year’s theme reflects a scholarly system in transition. While governments, funders, universities, publishers, and scholars are increasingly adopting open policies and practices, how these are actually implemented is still in flux. …

Open Access Week at IDIBELL Read More »

IDIBELL and ICO turn pink for Breast Cancer World Day

Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) will join the pink movement associated with the celebration of Breast Cancer World Day. Thus, the facade of the Duran i Reynals Hospital (Granvia de l’Hospitalet 199-203) will turn pink, the night of Friday, October 19th, World Day Against Breast Cancer, to remember the importance of early …

IDIBELL and ICO turn pink for Breast Cancer World Day Read More »

New scientific-technical equipment for IDIBELL

The Spanish ministry of science, innovation and universities has awarded  IDIBELL a grant (EQC2018-005246-P) worth approximately 93000€ to purchase a Seahorse 96, a high-throughput equipment for cellular metabolism and mitochondrial function analysis. This grant belongs to the 2018 call for the acquisition of scientific-technical equipment within the National R&D&I Plan 2017-2020.      

New therapeutic strategies for breast cancer

The risk of developing breast cancer is largely determined by the ability of the cells to repair damage to their DNA and, at the same time, by the regulation of the “stem cells” that may eventually become tumors. However, it is unknown how these two fundamental processes co-regulate.   In a recent study, IDIBELL – …

New therapeutic strategies for breast cancer Read More »

Statement on Dr Manel Esteller leaving IDIBELL

The Bellvitge Biomedical Research Institute (IDIBELL) states that Dr Manel Esteller, ICREA researcher, professor at the University of Barcelona, and until now, coordinator of the Epigenetics and Cancer Biology Program (PEBC) at IDIBELL, has been appointed director of the Josep Carreras Leukaemia Research Institute, a position that implies the termination of his employment relationship with …

Statement on Dr Manel Esteller leaving IDIBELL Read More »

Scroll to Top